Abiopharma

Arcus Biosciences - Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference

Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease

Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year

Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

Abivax to be Added to Nasdaq Biotechnology Index

Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference